Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.1 SEK | +0.59% | -0.58% | +10.61% |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
Apr. 17 | Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US | CI |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB